NRXS
Price
$2.58
Change
+$0.17 (+7.05%)
Updated
Jul 3 closing price
Capitalization
24.58M
75 days until earnings call
TSHA
Price
$2.45
Change
+$0.02 (+0.82%)
Updated
Jul 3 closing price
Capitalization
640.75M
44 days until earnings call
Interact to see
Advertisement

NRXS vs TSHA

Header iconNRXS vs TSHA Comparison
Open Charts NRXS vs TSHABanner chart's image
Neuraxis
Price$2.58
Change+$0.17 (+7.05%)
Volume$134.06K
Capitalization24.58M
Taysha Gene Therapies
Price$2.45
Change+$0.02 (+0.82%)
Volume$726.73K
Capitalization640.75M
NRXS vs TSHA Comparison Chart in %
Loading...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRXS vs. TSHA commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXS is a StrongBuy and TSHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (NRXS: $2.58 vs. TSHA: $2.45)
Brand notoriety: NRXS and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXS: 6% vs. TSHA: 17%
Market capitalization -- NRXS: $24.58M vs. TSHA: $640.75M
NRXS [@Biotechnology] is valued at $24.58M. TSHA’s [@Biotechnology] market capitalization is $640.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXS’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • NRXS’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, TSHA is a better buy in the long-term than NRXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXS’s TA Score shows that 6 TA indicator(s) are bullish while TSHA’s TA Score has 3 bullish TA indicator(s).

  • NRXS’s TA Score: 6 bullish, 3 bearish.
  • TSHA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NRXS is a better buy in the short-term than TSHA.

Price Growth

NRXS (@Biotechnology) experienced а +2.38% price change this week, while TSHA (@Biotechnology) price change was +1.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

NRXS is expected to report earnings on Sep 18, 2025.

TSHA is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($641M) has a higher market cap than NRXS($24.6M). TSHA YTD gains are higher at: 41.618 vs. NRXS (9.787). NRXS has higher annual earnings (EBITDA): -8.11M vs. TSHA (-85.47M). TSHA has more cash in the bank: 117M vs. NRXS (2.01M). NRXS has less debt than TSHA: NRXS (389K) vs TSHA (61.4M). TSHA has higher revenues than NRXS: TSHA (7.22M) vs NRXS (2.94M).
NRXSTSHANRXS / TSHA
Capitalization24.6M641M4%
EBITDA-8.11M-85.47M9%
Gain YTD9.78741.61824%
P/E RatioN/A2.70-
Revenue2.94M7.22M41%
Total Cash2.01M117M2%
Total Debt389K61.4M1%
TECHNICAL ANALYSIS
Technical Analysis
NRXSTSHA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECCPX48.510.47
+0.98%
Eaton Vance Tax-Managed Multi-Cap Gr C
RYRIX57.100.29
+0.51%
Rydex Retailing Inv
PWJRX33.330.08
+0.24%
PGIM Jennison International Opps R
PRPZX6.35-0.01
-0.16%
PGIM Jennison Energy Infrastructure Z
PCHSX30.70-0.09
-0.29%
Putnam Global Health Care C

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+7.05%
CVM - NRXS
58%
Loosely correlated
-1.19%
CTMX - NRXS
25%
Poorly correlated
+0.81%
NGNE - NRXS
24%
Poorly correlated
+4.69%
MRVI - NRXS
24%
Poorly correlated
+0.75%
TSHA - NRXS
23%
Poorly correlated
+0.82%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with XNCR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
+0.82%
XNCR - TSHA
42%
Loosely correlated
+1.45%
ERAS - TSHA
42%
Loosely correlated
-0.69%
DNTH - TSHA
40%
Loosely correlated
+2.56%
SLDB - TSHA
40%
Loosely correlated
+3.29%
TRDA - TSHA
39%
Loosely correlated
N/A
More